Clinical Evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx Amplified DNA Assay on the BD Viper™ System With XTR™ Technology
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 38 (7) , 603-609
- https://doi.org/10.1097/olq.0b013e31820a94d2
Abstract
Background: This study evaluated the performance of the BD ProbeTec Chlamydia trachomatis Qx (CTQ) Amplified DNA Assay on the BD Viper System with XTR Technology in a multicenter study. Methods: Specimens were collected at 7 geographically diverse clinical sites from 1538 women and men attending sexually transmitted disease, family planning, and obstetrics and gynecology clinics. There were 1465 evaluable participants, 993 women and 472 men. CTQ assay results from female endocervical, self-collected vaginal, male urethral swab specimens, and male and female neat (unpreserved) urine specimens as well as those obtained using the Urine Preservative Transport (UPT) tube for the CTQ assay were compared with patient-infected status (PIS). PIS was determined based on the combined results from Aptima Combo 2 and BD ProbeTec ET CT Amplified DNA Assay. Results: The sensitivity versus PIS for endocervical, vaginal, and both female urine samples was 91.3%, 96.5%, and 93.0%, respectively. The specificity for the same specimen types was 98.3%, 99.2%, and 99.4% (urine neat) and 99.2% (UPT), respectively. The sensitivity versus PIS for male urethral swabs and both male neat and UPT urine were 92.1% and 98%, respectively, with specificities of 98.4%, 99.2%, and 98.1%, respectively. Conclusions: The CTQ assay demonstrated performance characteristics comparable with other commercially available nucleic acid-based tests such as Aptima Combo 2 and BD ProbeTec ET CT-Amplified DNA assay. Vaginal swabs and male urine specimens, the sample types recommended by the Centers for Disease Control for chlamydia screening, both performed at least as well as other sample types evaluated.This publication has 23 references indexed in Scilit:
- Self‐obtained vaginal swabs for PCR chlamydia testing: A practical alternativeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Impact of Patient Characteristics on Performance of Nucleic Acid Amplification Tests and DNA Probe for Detection of Chlamydia trachomatis in Women with Genital InfectionsJournal of Clinical Microbiology, 2005
- Volume Effect on Sensitivity of Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens from FemalesJournal of Clinical Microbiology, 2003
- Preference Among Female Army Recruits for Use of Self-Administrated Vaginal Swabs or Urine to Screen for Chlamydia trachomatis Genital InfectionsSexually Transmitted Diseases, 2003
- Evaluation of Dry and Wet Transported Intravaginal Swabs in Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Female Soldiers by PCRJournal of Clinical Microbiology, 2002
- Evaluation of Use of a Single Intravaginal Swab to Detect Multiple Sexually Transmitted Infections in Active‐Duty Military WomenClinical Infectious Diseases, 2001
- Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral SwabsJournal of Clinical Microbiology, 2001
- Use of self-collected vaginal specimens for detection of Chlamydia trachomatis infection*1Published by Wolters Kluwer Health ,1998
- Prevalence of Isolated Urethral Asymptomatic Chlamydia trachomatis Infection in the Absence of Cervical Infection in Incarcerated Adolescent GirlsSexually Transmitted Diseases, 1993
- Chlamydia trachomatis-induced Urethritis in Female Partners of Men with Nongonococcal UrethritisSexually Transmitted Diseases, 1979